Details of the Drug

General Information of Drug (ID: DMDY117)

• Drug Name: ABBV-011

Indication

Disease Entry	ICD 11	Status	REF
Small-cell lung cancer	2C25.Y	Phase 1	[1]

• Drug Type: Antibody drug conjugate
• Cross-matching ID:
  DrugBank ID: DB18622
  TTD ID: D4J9HV

References

• [1] ClinicalTrials.gov (NCT03639194) A Study of ABBV-011 Alone and in Combination With Budigalimab (ABBV-181) in Participants With Relapsed or Refractory Small Cell Lung Cancer. U.S. National Institutes of Health.